Patient Engagement in the Management of Benign Prostatic Hyperplasia

Purpose of Review Benign prostatic hyperplasia (BPH) is an ideal disease model to consider the utility and impact of patient engagement since treatment choices, outcomes, and side effects are complex. The aim of this review is to evaluate existing research from 2015-2021 to identify established ways patient engagement has been applied to BPH as well as areas for improvement. Recent Findings Several studies describe the development and implementation of decision aids and new forms of informed consent to better facilitate patient engagement and decision-making. It has also been demonstrated that existing publicly available information about BPH is either difficult for patients to understand or is inaccurate. There are many medical and surgical options available for BPH management. Increased patient engagement, through patient education, decision aids, and shared decision-making, can address some of the unmet needs in BPH care.